Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Emails and messages left and NO response from company.
Still a shareholder, but not happy about their lack of info updating for shareholders regarding the Warning Letter from FDA.
$2, $5 or $20/share after settlement??? I hope it's at least $5
Our day will come, just buy a bunch at these low prices and wait for the settlement PR... boom...$2 at least for the PPS, $20/share if JnJ is generous to us!
Warning letter from FDA ruined the PPS. Too bad. Company refused to update shareholders what's going on...
if you're a concerned shareholder, just like me, Please call company at 303.415.2558 to ask about the Warning Letter from FDA http://www.fda.gov/ICECI/EnforcementActions/WarningLetters/ucm435662.htm
I left the message expressing my concerns about this warning letters and why the company doesn't address this problem in a PR yet (it's about a month already)... just afraid they will get halted...
First paragraph on page 5 of the 10k released yesterday:
On September 23, 2013, we announced our receipt of CE Mark certification to market Dario™. The receipt of the CE Mark (which incorporated positive data from clinical user performance studies undertaken in Israel) allows Dario™ to be marketed and sold in 32 countries across Europe as well as in certain other countries worldwide. On March 5, 2014, MDSS, our European Authorized Representative, completed the registration of the Dario™ Smart Meter with the German Authority as required by Article 10 of Directive 98/79/EC on in vitro diagnostic medical devices. With CE mark certification in hand, we accelerated our efforts to prepare and file with the U.S. Food and Drug Administration (or FDA) a Premarket Notification Application (known as a 510(k) application) for marketing of Dario™ in the United States, and on January 7, 2014, we announced the filing of our 510(k) application with the FDA for the Dario™ blood glucose monitoring system. We have received comments from the FDA on our submission during the third quarter of 2014. Following these comments, we have performed a clinical trial and other activities in order to respond to all FDA comments and on March 24, 2015, we announced the resubmission of our 510(k) application. We hope to receive FDA clearance of our 510(k) during 2015. We are also actively investigating regulatory clearance pathways for Dario™ in Asia and South America.
Sorry, My mistake, I just re-read the 10k and they filed 510k on Jan 7, 2014 and they just re-submitted on March 24, 2015. So by July 2015 we should hear back from FDA then.
The settlement offer from JnJ wasn't good enough so got rejected by DECN, I won't be surprised we will see a much better offer from JnJ and we'll in $$$ land.
501k submitted on Jan 7, 2015. FDA has 120 days to respond, so up to May 7, 2015. DRIO will go much higher in April.
I think it's OTC stocks, I'm seeing trades way lower and bids or much higher than asks' prices
No Way. Current vol is 115mil. OS is closed to 1Bil.
I agree 100%. Just a waiting game now.
bottom line is this stock is so cheap under 20cents, after settlement, it's going to be at least 10x.
VNDM sells shares @0.0009 now... when will the selling stop?
9.6mil shares just dumped at 0.0007 a minute ago.
Loaded before settlement, after settlement, SP will be in $$$ land. These are cheapies...
Conversion still going. VNDM is selling lot of shares currently.
That will be very helpful. Thanks. This warning letter is a road block for PKPH's future if the company won't be transparent about it.
Sent an email to the company asking about that warning letter from FDA, no response yet, it's been several days... too bad!
It said 'public offering' in the 8k
On March 3, 2015, Solar3D, Inc. (the “Company”) entered into an underwriting agreement (the “Underwriting Agreement”) with Cowen & Company, LLC (the “Underwriter”), relating to the sale and issuance by the Company of 3,000,000 Units (the “Units”) to the Underwriter in a firm commitment underwritten public offering (the “Offering”).
Did they sell all 3mil shares? If I add up the volumes in the last couple of trading days, still less than 3mil shares. I guess, they're not finished selling yet. Will add more when they're done selling.
Not sure if this warning is true. The letter dated 2/24/2015, the company didn't mention anything in its recent PRs on 2/26/2015 and 3/3/2015.
I'll try to contact them when I have a chance.
Agree. This co is the first of its kind (or one of the very first one) to provide hemp-based foods for pets. Seems like the company itself is surprised about the demand for Pets' hemp-based foods.
Bright Future ahead for Peak Pharmaceuticals. No doubt.
Up 50% today
pkph up 163%
Agree. Very Undervalued here. Mkt Cap is under $3mil. Partnered with Merck and 2 others. Got Patent.
This is a gem.
Great day today. Up 70%
Check the filings since June 2014, you'll see Reverse Merger written all over it.
Re-instated in June, 2014
Filed 15-12g in August, 2014
Letter of Attorney in Sept, 2014
Officer/Director changes in Jan, 2015
Now is the time to hold and accumulate more.
$QMDT (Quick-Med Tech) filed 15-12G Nov, 2013. OS 37Mil. AS 100Mil.
Current Market Cap only around $1.5Mil
Has products that are FDA approved. Big players partners.
TK
Looking good yesterday and today...
Good day today! Still holding all my shares to dollars' land.
CEO, CFO, Director bought bunch of them. Filings out today
up 86%
I hope that's the case. Then we all will be rewarded big here.
Why did they file 15-12G in 2013? the company won't have to file to SEC any more, this may be the reason the pps was down, other than that, it should trade in the dollars.
Dendreon had $340.3 million in assets and $660.7 million in liabilities on a book-value basis as of Sept. 30, according to court papers.
Read this link http://www.bloomberg.com/news/articles/2015-02-05/dendreon-s-price-jumps-35-before-bankruptcy-auction-even-starts
I thought we only need $665 mil for $1 PPS. Someone posted yesterday the company has $120mil in cash. Debt is $620mil. so $665 mil will make $1
Mkt Cap just a little bit over $3 mil @0.09. Very undervalued here.
Nah...they have 700mil (not 50 mil as other bio co) OS, too large for a bio company.
but this is 3 years away from any real approval, assume their phase 2 and phase 3, which haven't started yet, look good... 3 years is too far away...